Changes in metabolic parameters at basal, 3 months and 1 year and treatment indicated
| Basal parameters (V0) | Lipids at 3 months (V4) | Lipids at 1-year follow-up (V5) | Lipids at 2-year follow-up (V6) | |
| Triglycerides† (mg/dL) | 169 (122–248) | 111 (86–147) | 141 (103–195) | 138 (105–188) |
| Total cholesterol† (mg/dL) | 194±43.6 | 151±30.1 | 173±39.2 | 171±36.5 |
| LDL cholesterol† (mg/dL) | 115±38 | 85±24 | 109±33 | 106±31 |
| LDL cholesterol† (mg/dL) | ||||
| <50 years old | 105.5±34.4 | 83.11±20.2 | 108.8±31.8 | 106.8±31.3 |
| >50 years old | 118.5±38.7 | 85.9±25.9 | 109.1±33.2 | 105.8±31.3 |
| Basal | Treatment indicated in the first visit | Treatment indicated in visit 4 (3 months) (%) | How patients arrive at 1-year follow-up (%) | Treatment indicated in the first annual visit (%) | How patients arrive at 2 years (%) | Treatment indicated in the second annual visit (%) | |
| Patients without treatment (%) | 76.7 | 20.1* | 11.8* | 48.3 | 16.7 | 47.6 | 17.7 |
| Only statins (%) | 10.8 | 35.8* | 34.4* | 19.8‡ | 35.1 | 22.6 | 36.1 |
| Only fibrates (%) | 8.3 | 13.9 | 12.2 | 11.1 | 7.6 | 9.7 | 7.3 |
| Statin±fibrate (%) | 4.2 | 30.2* | 41.6* | 20.8‡ | 40.6 | 20.1‡ | 38.9 |
*P<0.001 comparing with basal evaluation (V0).
†Analysis of variance for lipid control parameters p<0.001.
‡P<0.001 compared with previous visit.
LDL, low-density lipoprotein.